Skip to content
Menu

Neurogene Inc. NGNE

Full chart Compare
Set alert

Price alert · NGNE

All alert types
22.93 USD -0.21 (-0.91%)

Regular-session close

23.50 +0.57 +2.49%

After hours · Nov 19, 5:15 PM ET

22.52 Day range 23.36
15.93 52-week range 43.66
YTD
+11.31%
1 year
+9.24%

Revenue & Expenses

Revenue Profit Costs
Other Income$7.47MGross Profit$925.00KNet Loss$75.14MExpenses$83.54MSelling, General & Admin$22.61MResearch & Development$60.92MInterest Expense$12.00KRevenue$925.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

NGNE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-103.33M-82.61M-55.58M-56.52M-60.70M
-90.35M-75.14M-36.32M-55.19M-60.69M
-4.24-4.28-117.28-139.88-22.00
NGNE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
104.18M136.93M148.72M82.02M142.47M
288.60M335.73M222.57M109.27M163.26M
23.72M25.36M36.55M10.64M20.40M
9.89M12.43M14.97M4.69M12.98M
264.89M310.38M186.02M-145.74M142.86M
NGNE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-77.17M-70.60M-51.42M-52.82M-47.56M
14.00M-125.26M25.64M-2.23M-3.26M
30.43M184.07M92.48M66.53M732.00K
-1.18M-808.00K-321.00K-2.23M-3.26M
-32.74M-11.79M66.70M11.48M-50.09M